Switch to:
GuruFocus articles
Headlines from internet
10:37AM10 Frightening Lung-Cancer Statistics and 3 Top Companies Looking to Do Something About It Fool
Nov-17-17$55.20 (+0.05%)
01:09PMBiotech Forum Daily Digest Herons Fda Approval Means Seekingalpha
08:53AMCancer Space Update: Label Expansion for Three Major Drugs Zacks
08:33AMDow 30 Stock Roundup: GE Cuts Dividend, Wal-Mart, Home Depot Beat Zacks
12:45AMDividend Challengers Near Challengers 58 Increases Expected End January Seekingalpha
Nov-16-17$55.17 (+0.68%)
06:13AMPharma Stock Roundup: FDA Nod for AstraZeneca Severe Asthma Drug, Bayer Signs Deal with Loxo Zacks
Nov-15-17$54.8 (-0.35%)
02:09PMTesaro Stock Could Have 41% Upside Barron's
12:32PMJ&J Presents Positive New Data for Diabetes Drug Invokana Zacks
12:22PMDow's stock bounces sharply to pace Dow gainers MarketWatch
11:45AMIBM shares fall after Warren Buffett slashes his stake by a third theStreet
Nov-14-17$54.99 (-0.2%)
02:02PMHealthcare Dogfight Glaxosmithkline Regains Top Gains November O And M And Patterson Close Seekingalpha
12:14PMDaily Pharma Scoop Heron Undervalued Theravance Submits Nda Nektar Continues Surge Seekingalpha
10:08AMHow to avoid the next GE — and find industrial winners of the future MarketWatch
08:29AMNovo Nordisk & 4 Other Pharma Stocks in Focus on World Diabetes Day Zacks
08:20AMMerck (MRK) Gets CHMP Nod for Infection Candidate Prevymis Zacks
06:46AMRough Year Dogs Dividends Seekingalpha
05:10AMKiss Dividend Strategy Worth 15 Percent Year Part 2 Seekingalpha
Nov-13-17$55.1 (-0.68%)
03:14PMHeron Therapeutics Looks Take Mercks Cinv Market Share Seekingalpha
02:06PMNektar/Bristol-Myers' Combo Trial Positive in Phase I/II Zacks
09:20AMStock Market News For Nov 13, 2017 Zacks
09:16AMBristol Myers Squibb Brings Ace Card Midst Ido Inhibitor Battle Seekingalpha
09:00AMCan Marijuana Cure Alzheimer's Disease? Fool
08:41AMSeattle Genetics' Adcetris Gets FDA Nod for Label Expansion Zacks
07:23AMIt's Not Too Late to Buy Dynavax Stock After Its Hepatitis B Vaccine Approval Fool
Nov-10-17$55.48 (-1.3%)
04:27PMTop Research Reports for Merck, UPS & Caterpillar Zacks
08:03AMPharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod Zacks
Nov-09-17$56.21 (-0.65%)
12:32PMAstraZeneca sales decline slows as it waits for medicine to work cnbc
10:10AMPharma ETFs Down Post Q3 Earnings Zacks
08:00AMAstraZeneca (AZN) Misses Q3 Earnings, Tweaks 2017 EPS View Zacks
06:02AMOncosec Presses Forward Positive Melanoma Combo Study Seekingalpha
Nov-08-17$56.58 (+1.78%)
01:14PMTrump holds an unprecedented presidential power cnbc
11:14AMNektar (NKTR) Q3 Earnings & Sales Surpass, Sales View Up Zacks
10:52AMHere's Why Merck & Co., Inc. Tanked 14% in October Fool
09:11AMCelldex (CLDX) Q3 Loss Narrows, Revenues Beat, Shares Up Zacks
Nov-07-17$55.59 (-0.52%)
06:02AMThe Only 3 Big Pharma Companies Growing Market Share Fool
04:47AMHorizon Pharma (HZNP) Tops Q3 Earnings & Sales, Ups View Zacks
Nov-06-17$55.88 (-0.32%)
03:45PMBiotech Forum Daily Digest Adamas Soaring Seekingalpha
12:43PMGlaxo vs Gilead: Put ‘Em Up? Barron's
12:02PMComments Q3 Results Merck Pfizer Bristol Myers Novo Nordisk Seekingalpha
09:47AMDynavax Reaches Finish Line Triumph Stumble Seekingalpha
08:31AMImmunoGen (IMGN) Q3 Loss Wider Than Expected, Cash View Up Zacks
07:32AMPharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for Kymriah Zacks
07:28AMMerck Slow Steady Dividend Grower Better Alternatives Exist Seekingalpha
04:50AMTracking Kahn Brothers Portfolio Q3 2017 Update Seekingalpha
Nov-03-17$56.06 (+1.25%)
10:39AMDow 30 Stock Roundup: Chevron, Exxon, Apple Earnings Impress Zacks
Nov-02-17$55.37 (+0.05%)
09:36AMExelixis (EXEL) Beats Q3 Earnings on Solid Cabometyx Sales Zacks
08:34AMSanofi (SNY) Q3 Earnings In Line, Sales Lag, Diabetes Weak Zacks
04:01AMMicrosoft Apple Visa Top Gain Safer Dividend Dow Dogs Per Broker October Estimates Seekingalpha
Nov-01-17$55.34 (+0.45%)
04:07PMBiotechs Behaving Badly Analysis Seekingalpha
02:05PMThere's Plenty of Volatility Out There. Just Look at AMD and Amazon theStreet
11:49AMDow Dog Gains Topped Ge Microsoft And Apple Per Broker October Targets Seekingalpha
11:10AMRoach Motel Something Wicked Part Ii Seekingalpha
11:05AMAduro (ADRO) Q3 Loss In Line With Estimates, Revenues Miss Zacks
07:18AMBuying Merck 52 Week Lows Seekingalpha
06:45AMGlaxosmithkline Comparative Analysis Potential Takeover Targets Cash Flow Dividend Seekingalpha
Oct-31-17$55.09 (+0.69%)
03:08PMBig Pharma: Win Some, Lose Some Barron's
01:50PMDow jumps 4.2% in October, powered by Intel, Microsoft and Wal-Mart MarketWatch
11:18AMMercks Keytruda Just Suffered Large Setback Seekingalpha
09:50AMBiotech Forum Daily Digest Possible Buyout Scenarios Neos Therapeutics Seekingalpha
09:28AMStock Market News For Oct 31, 2017 Zacks
03:00AMBiotech Analysis Central Daily Pharma News October 30 2017 Seekingalpha
Oct-30-17$54.71 (-6.06%)
05:09PMWhat Happened in the Stock Market Today Fool
04:09PMWashington Uncertainty and a Healthcare Selloff Send Stocks Off Kilter theStreet
12:21PMBiotech Forum M Will Pick 2018 Seekingalpha
12:14PMWhy What's Bad for Merck Is Good For Bristol-Myers Barron's
12:04PMMidday Update: Stocks Mixed as Healthcare Struggles, Tech Continues Gains theStreet
11:48AMGM Takes Down Consumer Stocks, Tech Rally Fails to Hold Up theStreet
11:32AMCorning 35 Early 2018 Yes Optical Sales Continue Soar Seekingalpha
09:41AMWhat's in the Cards for PFE, INCY and ACOR in Q3 Earnings? Zacks
09:36AMStocks Fall as Mueller Probe Triggers Uncertainty in Washington, Wall Street theStreet
09:26AMStock Market News For Oct 30, 2017 Zacks
05:35AMMerck Shares Drop in Premarket After European Keytruda Application Withdrawn theStreet
03:03AMMerck Appeal Lures Driven Keytruda Core Struggles Seekingalpha
08:15AMA Me-Too Push By Biopharma Is Crowding the Psoriasis Market Fool
08:08AM3 Bright Spots in Merck's Q3 Results Fool
08:00AM3 Things October 29 2017 Mercks Big Pivot Novocure Moves Lung Abbvies Priority Review Seekingalpha
Oct-27-17$58.24 (-6.05%)
04:07PMNasdaq Explodes With Best Gains Since November in Tech-Driven Rally theStreet
03:41PMApple's stock rally stands out for the Dow MarketWatch
03:34PMDow industrials threaten to record worst performance versus the Nasdaq in 15 years MarketWatch
01:54PMGilead Bad News Good News Guesses Seekingalpha
11:58AMNasdaq on track for best daily rise in nearly a year as technology sector powers record rally MarketWatch
11:38AMBig Gains for Nasdaq as Amazon and Alphabet Give Tech Stocks a Big Boost theStreet
10:51AMNasdaq Composite on track for best daily rise since before Election Day as tech powers record rally MarketWatch
10:29AMMicrosoft's record stock rally delivers more than 45-point tailwind to Dow industrials MarketWatch
10:29AMMicrosoft's record stock rally delivers more than 45-point tailwind to Dow industrials MarketWatch
10:11AMMerck (MRK) Q3 Earnings Top, Sales Lag, Keytruda Stays Strong Zacks
09:42AMData and Earnings Deluge Zacks
09:38AMDow dragged lower by Chevron, Merck; S&P 500, Nasdaq rally at the open on tech earnings MarketWatch
09:32AMMerck profit beat clouded by NotPetya attack, shares dip cnbc
09:27AMQ3 GDP Hits 3.0%, Q3 Earnings Take Pre-Market Higher Zacks
09:24AMStop Worrying About Valuations After Amazon, Alphabet and Microsoft's Earnings theStreet
08:58AMGilead (GILD) Down on Weak HCV Sales Despite Q3 Earnings Beat Zacks
07:50AMPharma Stock Roundup: Lilly Tops on All Fronts, Mixed Results from Bristol-Myers Zacks
07:44AMMerck (MRK) Tops on Q3 Earnings, Ups View Despite Sales Miss Zacks
07:30AMJuniper Pharmaceuticals High Risk High Reward Womens Health Play Seekingalpha
07:24AMThe Zacks Analyst Blog Highlights: Merck, Pfizer, Aetna and Electronic Arts Zacks
07:02AMMerck's stock rallies after profit beat, raised outlook offset sales miss MarketWatch
06:54AMUS stock futures rise after big tech earnings crush the Street cnbc
06:53AMHow high can Amazon go? Legendary trader sees 10% pop on top of today’s surge MarketWatch
05:55AMGoogle, Amazon, Aetna and Exxon - 5 Things You Must Know Before the Market Opens Friday theStreet
04:39AMAmazon, Microsoft, Alphabet set to power Nasdaq higher after blowout results MarketWatch
Oct-26-17$61.99 (-0.74%)
04:13PMCelgene Crashes Reassessment Seekingalpha
02:11PMEarningsWatch: Celgene tanks and Twitter spikes ahead of Amazon, Alphabet reports MarketWatch
11:31AMGlaxo (GSK) Q3 Earnings Beat, Revenues In Line, Shares Down Zacks
09:49AMCelgene (CELG) Tops Q3 Earnings, Sales Miss, Updates View Zacks
09:06AMKey Predictions for Q3 Earnings Reports of ABBV, MRK Zacks
07:26AMMerck vs. Pfizer: Which is Better Ahead of Q3 Earnings? Zacks
06:23AMBiotech Analysis Central Daily Pharma News October 25 2017 Seekingalpha
Oct-25-17$62.45 (-1.05%)
07:00PM20 Companies Goldman Sachs Thinks Will Be Huge Winners from Trump's Big Tax Plan theStreet
02:38PMU.S. Committee backs Glaxo's shingles vaccine MarketWatch
11:42AMRoche Buying Dip Seekingalpha
09:53AMWhat to watch in Bayer earnings: Monsanto deal MarketWatch
08:41AMIs a Beat in Store for Agenus (AGEN) This Earnings Season? Zacks
05:34AMIs a Beat Likely for Pfizer (PFE) This Earnings Season? Zacks
Oct-24-17$63.11 (-0.46%)
11:05AMAnti Amyloid Approach Alzheimers Disease Failed Seekingalpha
09:35AMCan AbbVie (ABBV) Spring a Surprise this Earnings Season? Zacks
08:39AMHealthcare ETFs Set to Soar as Q3 Earnings Unfold Zacks
06:01AMWill Merck (MRK) Keep the Earnings Streak Alive in Q3? Zacks
03:22AMEarningsWatch: Amazon, Alphabet and AMD form tech’s A list MarketWatch
Oct-23-17$63.4 (-0.75%)
09:30AMIs a Beat in Store for Bristol-Myers (BMY) in Q3 Earnings? Zacks
09:23AMGlaxosmithkline Lands Big Win Shingles Vaccine Seekingalpha
07:41AMGame Plan Week Cramers Mad Money 10 20 17 Seekingalpha
01:00AMTuesday Was Blacker Than Monday; Tax Reform's Role -- Jim Cramer's Top Thoughts theStreet
12:01AMApple and Nike show that stock performance is linked to how CEOs spend money MarketWatch
06:26PMFutures and Dollar Rise as Trump Narrows Down Pool for Next Fed Chair theStreet
10:00AMThird-Quarter U.S. Economic Growth to Reveal Hurricane Damage in Week Ahead theStreet
Oct-20-17$63.88 (+0.2%)
06:49PMGet Ready for an Earnings Onslaught: Cramer's 'Mad Money' Recap theStreet
05:51PMMerck to lay off about 1,800 U.S. sales reps in cost-cutting move MarketWatch
04:51PMRoche (RHHBY) Reports Sales Numbers for First 9 Months Zacks
04:43PMCelgene Down on Discontinued Crohn's Disease Drug Study Zacks
04:28PMCancer Treatment Update: Second Gene Therapy Receives Approval Zacks
03:04PMBioLineRx/Roche Scan BL-8040-Tecentriq for Gastric Cancer Zacks
01:57PMMerck to cut 1,800 US sales jobs, add 960 in chronic care cnbc
01:44PMMarket Skeptical Roche Ahead Major Trial Read Outs Seekingalpha
07:47AMPharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling Zacks
Oct-19-17$63.75 (+0.38%)
10:00AMWall Street Has Changed A Lot Over the Past 30 Years theStreet
09:38AM6 Dow Stocks Fairly Valued Part 4 5 Seekingalpha
09:00AM3 Things Biotech Learn Today October 19 2017 Seekingalpha
08:30AMAstraZeneca's sNDA for Two Cancer Drugs Gets Priority Review Zacks
07:40AMMarket Waiting Tax Reform Cramers Mad Money 10 18 17 Seekingalpha
02:45AMKiss Dividend Strategy Worth 15 Percent Year Seekingalpha
Oct-18-17$63.51 (+0.46%)
06:55PMRally's Not Waiting on Tax Reform: Cramer's 'Mad Money' Recap theStreet
03:59PMPricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
03:32PMBit Biopharma Investing Seekingalpha
03:21PMWhat to Expect from Big Pharmas After J&J's Solid Q3 Results? Zacks
02:28PMMerck: Is Keytruda a $16B Drug? Barron's
01:35PMVision Clear Listen Merck Invest Microcap Kalvista Pharmaceuticals Seekingalpha
11:23AM16 61 Safer Dividend Healthcare Dogs October Seekingalpha
09:55AMMerck Stock Edges Higher as Citi Forecasts Strong Sales theStreet
09:36AMHealthcare Dogfight Owens And Minor Edges Glaxosmithkline Top Broker Pick Gains October Seekingalpha
08:58AMExploring Astrazenecas Two Prong Assault Lung Cancer Seekingalpha
07:35AMAstra and Merck win speedy review for Lynparza in breast cancer cnbc
Oct-17-17$63.22 (-0.19%)
11:51AMDynavax Reports Good News Seekingalpha
09:37AMJ&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales Zacks
08:49AMBristol-Myers Gets Priority Review for Opdivo Label Expansion Zacks
Oct-16-17$63.34 (-0.08%)
05:10PMMercks Risk Reward Compelling Seekingalpha
01:52PMMerck Pulls Plug Cholesterol Drug Seekingalpha
11:21AMSanofi Upward Trajectory 2017 Seekingalpha
10:58AMThese stocks have popped more than 75% since Trump was elected MarketWatch
10:44AMWhat Goes Up….Is Bristol-Myers a $48 Stock? Barron's
12:00AMDrug Companies Fear Brexit Will Hit Medicine Trade Bloomberg
10:33AMBetter Buy: AbbVie Inc. vs. Merck Fool
Oct-13-17$63.39 (-0.69%)
04:59PMRoche Allergan Approaches Alzheimers Seekingalpha
12:21PMLost beneath headlines of five-figure drug costs — pharmaceutical price growth is weakening MarketWatch
11:40AMDaily Pharma Scoop Seeking Alpha Interview Spark Adcom Nod Luxturna Pfizer Lyrica Approval Seekingalpha
10:30AMPfizer: Could a Big Merger Move the Needle? Barron's
10:18AMCancer Space Update: Lung & Breast Cancer Studies in Focus Zacks
07:06AMPharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback Zacks
Oct-12-17$63.83 (+0.08%)
02:30PMMerck Will Not Seek Approval for CETP Inhibitor Anacetrapib Zacks
01:07PMLower Volatility Stock Portfolio Retirees Others Seekingalpha
11:25AMArdian Is Said to Hire Banks to Weigh Sale of Germany's Riemser Bloomberg
10:51AMNIH partners 11 drugmakers to accelerate cancer therapy research cnbc
09:18AMSeattle Genetics Inks Clinical Collaborations for Cancer Drug Zacks
06:00AM5 Game-Changing Cancer Drug Innovations Being Developed Right Now Fool
Oct-11-17$63.78 (-1.05%)
11:46AMBiotech Analysis Central Daily Pharma News Seekingalpha
09:40AMLilly's (LLY) Verzenio Fails in Phase III Lung Cancer Study Zacks
09:29AMSeattle Genetics Begins Phase II Study of Cancer Candidate Zacks
08:46AMCompany News For Oct 11, 2017 Zacks
Oct-10-17$64.46 (+0.2%)
12:51PMRT @bydavidcrow: Decoding cancer: the four trends that are turning precision medicine into a reality Financial Times
Oct-09-17$64.33 (-0.34%)
04:05PMAgenus Loads Impressive New Pipeline Seekingalpha
11:34AMThe 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September Fool
09:00AMPfizer Growth Trajectory Locked Ready Launch Seekingalpha
08:00AM3 Things Biotech Learn Today October 7 2017 Seekingalpha
Oct-06-17$64.55 (-0.08%)
07:18AMEverything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now? Fool
Oct-04-17$64.6 (+0.36%)
02:02PMBest Healthcare Stocks Abbvie Seekingalpha
09:32AMA breakout in this cheap, forgotten stock is powering the Dow Jones Industrial Average MarketWatch
Oct-03-17$64.37 (-0.28%)
03:32PMJohnson And Johnson Best Breed Healthcare Seekingalpha
07:30AMOno Pharmaceutical Needs Reinvest Windfall Seekingalpha
05:59AMTax Reform Effect Small Cap High Cash Flow Stocks Part 2 Seekingalpha
Oct-02-17$64.55 (+0.81%)
02:29PMHere are the actual tax rates the biggest companies in America pay MarketWatch
05:19AMStarting Point Big Pharma Novartis Sanofi Clear Hurdles Seekingalpha
08:21AM3 Things Biotech Learn Today October 1 2017 Seekingalpha
Sep-29-17$64.03 (-0.4%)
12:27PMIntercept Runs Trouble Nash Developers Like Galectin Gain Value Seekingalpha
Sep-28-17$64.29 (-0.43%)
10:59PMSafer Dividend Dow Dogs Go Apple Disney Ibm Gains Per Broker September Estimates Seekingalpha
03:44PMGlaxosmithkline Get Ready Dividend Cut Pharma Giant Seekingalpha
11:33AMCelldex Therapeutics Buy Part 2 Seekingalpha
11:23AMGilead Spruces Large Target Market Seekingalpha
Sep-27-17$64.57 (-0.29%)
10:52AMBiotech Forum Daily Digest Still Gains Ahead Dynavax Seekingalpha
Sep-26-17$64.76 (-0.64%)
06:25AMDaily Pharma Scoop Alnylams Big Win Aradigm Nda Rating Exel Azn Japan Expansions Seekingalpha
Sep-25-17$65.18 (+0.08%)
12:04PMHurricane Lessons Seekingalpha

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat